Abstract
Intestinal ultrasound has been proven to be a useful as a screening tool in patients with clinically suspected Crohn’s disease as well as in the follow-up of patients already diagnosed with Crohn’s disease. In these patients, it is possible to assess the site and extent of the lesions and ensure early detection of intra-abdominal complications, in particular abscesses and strictures. Intestinal ultrasound may be also used for monitoring Crohn’s disease following surgery, revealing early recurrence of the disease and suggesting the clinical and endoscopic outcome. Despite several attempts to correlate the ultrasonographic findings with Crohn’s disease activity, to date, only ultrasonographic assessment of endoscopic activity is convincing.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
1 Introduction
Abdominal ultrasound (US) thanks to its accuracy, good repeatability and noninvasiveness is currently employed in many chronic inflammatory conditions, not only for purely diagnostic purposes, but also for management of the disease. In Crohn’s disease (CD) patients, US has become the first-line imaging procedure for early diagnosis of the disease (Parente et al. 2004a), and more frequently for the follow-up, to detect intra-abdominal complications (strictures, fistulae and abscesses), to assess activity and monitor the course of disease, as a prognostic index of recurrence (Table 1).
2 Pathological Features
Crohn’s disease is a chronic granulomatous inflammatory condition of the alimentary tract of unknown origin. Although there are no pathognomonic features of the disease, it is characterised by a segmental and transmural inflammation of the intestinal wall, particularly ileum (30 %), colon (20 %) or both the large and small bowel (50 %). Macroscopically, the bowel wall often appears greatly thickened, and hypo-elastic or stiff with luminal narrowing (Fig. 1).
Mucosal abnormalities consist of longitudinal and aphtous ulcerations, which, in advanced disease, may penetrate into the submucosa and muscularis leading the serosa and outside, creating fissures and fistulas. These may invade the adjacent loops, organs, skin or end blindly in the mesentery, sometimes resulting in intra-abdominal or retroperitoneal abscesses. The mesentery is often thickened and fatty, surrounding the thickened walls and containing enlarged lymph nodes.
3 Ultrasonographic Features of Bowel Walls
The abnormalities of bowel wall include bowel wall thickening, alterations of bowel wall echopattern, hyperemia, loss of elasticity and peristalsis, creeping fat and mesenteric lymph nodes. Intra-abdominal complications of CD typically include stenoses and obstruction, fissures and fistulae, inflammatory masses (phlegmon or abscesses).
3.1 Bowel Wall Thickening
US examination in CD patients frequently reveals stiff and thickened bowel walls, usually >4 mm (which is considered the limit of normal bowel wall for the ileum and colon) up to 15 mm. The wall thickness of a diseased segment is measured in a transverse section from the central hyperechoic line of the lumen (representing interface between content of the lumen and the mucosa) to the outer hyperechoic margin of the wall (representing the serosa) (Fig. 2). Literature usually considers the maximum bowel wall thickness, that can be reproduced along the bowel wall for at least 2–4 cm.
The abnormal thickening of bowel walls is the most widely and commonly US finding reported in the literature to diagnose CD. In a meta analysis aiming at evaluating the impact of different cut-off values of bowel wall thickening (3 vs 4 mm) in determining the presence of CD, it has been shown that when a >3-mm cut-off level was observed for abnormality, sensitivity and specificity were 88 and 93 %, respectively, whilst when a cut-off level of >4 mm was used sensitivity was 75 % and specificity 97 % (Fraquelli et al. 2005). The accuracy of US in detecting CD has been also compared with that of other cross-sectional imaging techniques, in a systematic review. This study showed that US has high accuracy for evaluation of suspected CD (overall per-patient sensitivity and specificity: 85 and 98 %, respectively), comparable to that of magnetic resonance imaging (MRI) (overall per-patient sensitivity and specificity: 78 and 85 %, respectively) (Panes et al. 2011).
However, these remarkable data also show that intestinal US, even in expert hands, may result in false-negative and false-positive findings. False-negative findings may be in obese patients or when CD is characterised by only superficial lesions, such as rare aphtous ulcers or mucosal erosions (Maconi et al. 1996a). False-positive findings rely on the fact that thickening of the bowel walls is not specific for CD, being present also in infectious, neoplastic and other inflammatory diseases (Truong et al. 1998). Therefore, when US is used as a first imaging diagnostic procedure, the diagnosis of CD is suggested when wall thickening involves the terminal ileum, is circumferential and segmental. However, the definitive diagnosis—when possible, and always for colonic lesions—should rely on endoscopic and histological examinations of pathological tissues. US may represent a useful tool, prior to other invasive or expensive diagnostic investigations, which can be postponed in the case of negative US findings.
In CD patients, US can be usefully employed in localising CD lesions within the bowel (particularly ileal lesions, which can be detected in more than 90 %) and in assessing the length of small bowel involvement (Brignola et al. 1993; Maconi et al. 1996a; Parente et al. 2003, 2004a, 2011).
The clinical significance of the degree of thickening of diseased bowel wall in CD is controversial. Several studies attempted to establish a relationship between maximum bowel wall thickness and clinical severity (Crohn’s disease activity index, CDAI) and biochemical activity (Erythrocyte Sedimentation Rate, C Reactive Protein) of CD. However, almost all the results of these studies produced weak correlations, although somewhat significant (Maconi et al. 1996a; Futagami et al. 1999; Mayer et al. 2000; Bru et al. 2001; Haber et al. 2000, 2002; Parente et al. 2003). On the contrary, the thickening of bowel wall significantly correlates with endoscopic activity of CD. It has been shown that US thickening of bowel wall has an overall high sensitivity and specificity (85 and 91 %, respectively) for the detection of endoscopic active CD (Panes et al. 2011).
Likewise, the US assessment of bowel wall thickening is useful to identify postoperative recurrences following resection, to assess the efficacy of conservative surgical treatment, and to obtain predictive data on the risk of recurrences in these patients. Postoperative endoscopic recurrences of CD may be correctly identified using bowel US in more than 80 % of patients (Di Candio et al. 1986; Andreoli et al. 1998). Moreover, US offers the possibility to assess the behaviour of diseased bowel walls following conservative surgery (namely strictureplasty and miniresection), in CD patients. In fact, in patients showing an improvement or return to normality of the bowel wall thickening 6 months after conservative surgery, the clinical and surgical recurrence rate have being significantly lower than in those maintaining the same level of bowel wall thickening (Maconi et al. 2001). Likewise, it has been shown that a high bowel wall thickness (>7 mm) at US is a major risk factor for intestinal resection (Rigazio et al. 2009; Castiglione et al. 2004).
Therefore, bowel US offers a useful alternative to invasive procedures in the postsurgical follow-up of CD patients, in particular for those CD patients who have undergone conservative surgery in whom endoscopy is not suitable to identify CD patients at high risk of clinical and surgical relapse, thus offering the opportunity to tailor the appropriate postoperative medical treatment.
3.2 Bowel Wall Echopattern
The thickened bowel wall in CD may show different echopattern. It may maintain the regular stratification (Fig. 2) or may be characterised by a partial or complete loss of layering. Sometimes, bowel segments with alternate persistence and loss of stratification, may be observed.
In stratified echopattern, the thickened walls display a variable enlargement of the mucosal, submucosal or muscular layers. Often the layer corresponding to the submucosa is thicker than others (Fig. 3a). The echo-stratification may be interrupted by hypoechoic areas (some with hyperechoic spots) corresponding to deep ulcers (Fig. 3b), or may completely disappear (Fig. 3c). The disappearance of echo-stratification indicates the presence of large, deep longitudinal ulcers associated with intense inflammation and neovascularisation (Kunihiro et al. 2004).
The clinical and pathological significance of bowel echopattern and, in particular, its importance in defining CD activity has been investigated in two studies, one of which in patients with stenosis. In vitro studies, that compared US images with the in vitro histopathological findings of related resected specimens, showed that the loss of stratification (hypoechoic echopattern) correlated with the severity of inflammation and that persistence of stratification in bowel wall of strictures suggested a high degree of fibrosis within the submucosa and muscularis mucosae (Hata et al. 1994; Maconi et al. 2003a). A recent study showed that fibrosis is correlated with an increase of echogenicity in the muscularis propria and a decrease of echogenicity in the submucosa (Nylund et al. 2008).
3.3 Bowel Wall Vascularity
The increased vascularity is often observed in bowel wall with decreased echogenicity. This is likely due to hyperaemia and neovascularisation related to the increased inflammatory response (Maconi et al. 2003a; Di Sabatino et al. 2004). Therefore, vascularity within the thickened bowel walls, assessed by power-color Doppler US, has been used as an index of CD activity (Fig. 4).
Vascularity has been evaluated using a simple scoring system according to the semi-quantitative (and subjective) intensity of colour signals and/or by analysis of Doppler curves (measurement of resistive index) obtained from vessels detected within the bowel walls. However, neither of these parameters correlated well with clinical or biochemical activity in most studies, whereas often a significant correlation was often found between vascularity and endoscopical/radiological activity (Spalinger et al. 2000; Esteban et al. 2001; Haber et al. 2002; Heyne et al. 2002; Scholbach et al. 2004; Neye et al. 2004; Yekeler et al. 2005).
The vascularity of diseased bowel walls in CD has been recently assessed by US i.v. contrast agents. This issue will be widely discussed elsewhere (see “Intravenous contrast-enhanced bowel ultrasound”).
3.4 Elasticity and Peristalsis
Thickened bowel walls in CD may be associated with reduction or absence of peristalsis in the small bowel and loss of haustra coli in the colon (Sarrazin and Wilson 1996; Di Mizio et al. 2004). Although this manifestation is quite subjective and difficult to quantitatively assess, it has been regarded as relevant sign in most US studies, probably because associated with intestinal stenosis. Waiting for the results of US elastography (see “Imaging of Tissue Elasticity in Gastrointestinal Disorders”), oral contrast agents may be used for a more accurate US assessment of this feature (Parente et al. 2004b).
3.5 Mesenteric Hypertrophy and Mesenteric Lymph Nodes
Mesenteric hypertrophy (also named mesenteric fibrofatty proliferation or creeping fat) appears at US as hyperechoic, sometimes inhomogeneous area surrounding thickened bowel walls (Fig. 5). It is found in up to 50 % of CD patients (Goldberg et al. 1983; Maconi et al. 2008) and is correlated with biochemical and clinical activity of CD and with internal fistulas and increase bowel wall thickness (Maconi et al. 2008).
Enlarged mesenteric lymph nodes appear at US as oval, homogeneous hypoechoic nodules with regular margins (Fig. 6). This is a frequent finding in CD patients, in particular in young CD patients, in an earlier phase of CD and in patients with septic complications such as internal fistulas and abscesses. Its prevalence and clinical significance is discussed elsewhere in this book (see “Mesenteric Lymphadenopathy”).
4 Crohn’s Disease Abdominal Complications
The clinical course of CD is often characterised by abdominal complications such as stenosis, fistulae or abscesses and rarely by free perforation.
4.1 Stenosis and Intestinal Occlusion
Stenosis develops in 21 % of patients with ileal CD and in 8 % of those with ileocolic disease (Fenoglio-Preiser et al. 1989; Simpkins and Gore 1994). It is the most frequent cause of surgery. The diagnostic gold standard of this complication is contrast radiography that reveals all the occluded sites, the degree of intestinal narrowing and the length of the stenotic segments.
Bowel stenosis can be revealed by US as thickened bowel walls, associated with narrowed lumen and increased diameter of the proximal loop >2.5–3 cm. Acute stenoses are often associated with a variable amount of liquid and gas within the lumen of the proximal loop and with increased peristalsis (Fig. 7a) (Ko et al. 1993). In chronic, non-occlusive, stenoses the amount of air within the proximal loop prevails, and peristalsis is usually weak (Fig. 7b).
Using this definition, US correctly diagnoses stenosis in 70–79 % of unselected CD patients and in >90 % of patients with severe intestinal stenoses needing surgery, with false-positive diagnoses limited to 7 % (Maconi et al. 1996b; Gasche et al. 1999; Parente et al. 2002, 2004b). Results may be even better using an oral contrast agent (see “Intravenous Contrast-Enhanced Bowel Ultrasound”) and are comparable to those of MRI and computed tomography (Table 2; Panes et al. 2011).
US assessment of the echopattern of the bowel wall of the strictures may also offer an insight into the histological features, discriminating between fibrotic and inflammatory strictures (Maconi et al. 2003a). Loss of stratification of the bowel wall at the level of the stricture suggests its inflammatory nature with a low degree of fibrosis, whilst the presence of stratification suggests a higher degree of fibrosis of the stenosis (Fig. 8a, b).
4.2 Sinus Tracks and Fistulae
Fistulae occur in 17–82 % of CD patients. They are a transmural extension of the disease, often resulting from intestinal stenosis (Oberhuber et al. 2000), which ends blindly in the surrounding mesentery or connects intestinal loops or adjacent organs. Depending on their site and extension, abdominal fistulae are commonly subdivided into external or internal (enteroenteric, enteromesenteric).
Fistulae may appear on US as hypoechoic ducts or hypoechoic areas between intestinal loops or between loops and other structures such as the bladder (enterovescical fistula) or the skin (enterocutaneous fistulae) (Fig. 9a, b, c). Sometimes, fistulae display internal echoic spots due to the presence of air, debris or intestinal material (Maconi et al. 1996b; Gasche et al. 1999).
At present, there is no reliable technique for the diagnosis of this complication. Using surgical findings as reference standard, we showed that the accuracy of US and X-ray studies in detecting internal fistulae was comparable, with a sensitivity of 71.4 % for US and 69.6 % for X-ray studies, and a specificity of 95.8 % for both. We also showed that the combination of these two techniques significantly improved preoperative diagnostic performance (sensitivity 97.4 % and specificity 90 %) and that in selected severe cases of CD, with clinical suspicion of septic complications (i.e. abdominal mass or fever), sensitivity of US is even higher (88.5 %), thus confirming the high sensitivity of a previous US study (Gasche et al. 1999; Maconi et al. 2003b).
Noteworthy, US, MRI and CT have comparable sensitivity and specificity in detecting internal fistulae in CD (Panes et al. 2011). Since fistula wall is characterised by granulation tissue and neoangiogenesis, it may be easily recognised at US by detecting intra-mural blood flow using power-Doppler or i.v. contrast-enhanced US (Maconi et al. 2002).
US may also be usefully employed to define the features of external fistulae, particularly if US is combined with the injection of echoic contrast medium composed of hydrogen peroxide and povidone iodine into the fistula. This sort of US fistulography defines the extension and the configuration (linear or with ramifications) of the enterocutaneous fistulae (Fig. 10) is well tolerated and does not expose the patient to the risk of septic dissemination during the injection of the contrast medium (Maconi et al. 1999).
4.3 Intra-Abdominal Abscesses and Inflammatory Masses
Intra-abdominal abscesses occur in 12–30 % of CD patients, usually as a consequence of fistulising disease or as a postoperative complication (Steinberg et al. 1973; Nagler et al. 1979). At US, abscesses appear as hypoanechoic lesions with fluid collection and irregular thickened walls, sometimes containing internal echoes due to the presence of debris or air, and characterised by a posterior echo enhancement (Fig. 11). Hypoechoic masses, especially those of small size and located close to the intestine, may be missed or mistaken for large sinus track, hypoechoic lymph nodes or phlegmon. Conventionally, these lesions are diagnosed when characterised by irregular borders, no identifiable wall or liquefaction. Inflammatory masses, phlegmons and intra-abdominal abscesses, identified or suspected at US, may be confirmed and distinguished detecting vascular signals by color-power Doppler US or, better, by i.v. contrast-enhanced US, around and/or within the lesions. Phlegmon and inflammatory masses, in fact, show increased colour signals within (Fig. 12), whilst abscesses present fluid collections with a peripheral flow (Fig. 13) (Tarjan et al. 2000; Maconi et al. 2002).
US detection of intra-abdominal abscesses shows a mean sensitivity and specificity of 84 and 93 %, respectively, quite similar to those of MRI and CT (Table 2; Panes et al. 2011). In particular, US shows a higher sensitivity in the detection of superficial intra-peritoneal abscesses, while the diagnosis of deep pelvic or retroperitoneal abscesses is more difficult due to the presence of overlying bowel gas and the difficulty in differentiating an abscess from an intestinal loop with stagnating fluid.
4.4 Perforation
Perforation is a potentially lethal complication of CD. It occurs in 1–2 % of the patients as a consequence of deep fissures in the intestinal wall. Free perforation should be suspected when US shows the presence of intra-peritoneal liquid and air, indicative of purulent peritonitis or the presence of free air under the diaphragm.
Focal perforations are more frequent than free perforations and may be diagnosed by US as areas of asymmetric and focal thickening of the wall associated with small periparietal collections of liquid and air.
References
Andreoli A, Cerro P, Falasco G et al (1998) Role of ultrasonography in the diagnosis of postsurgical recurrence of Crohn’s disease. Am J Gastroenterol 93:1117–1121
Brignola C, Belloli C, Iannone P et al (1993) Comparison of scintigraphy with indium-111 leukocyte scan and ultrasonography in assessment of X-ray-demonstrated lesions of Crohn’s disease. Dig Dis Sci 38:433–437
Bru C, Sans M, Defelitto MM et al (2001) Hydrocolonic sonography for evaluating inflammatory bowel disease. AJR Am J Roentgenol 177:99–105
Castiglione F, de Sio I, Cozzolino A et al (2004) Bowel wall thickness at abdominal ultrasound and the one-year-risk of surgery in patients with Crohn’s disease. Am J Gastroenterol 99:1977–1983
Di Candio G, Mosca F, Campatelli A et al (1986) Sonographic detection of postsurgical recurrence of Crohn disease. AJR Am J Roentgenol 146:523–526
Di Mizio R, Maconi G, Romano S et al (2004) Small bowel Crohn disease: sonographic features. Abdom Imaging 29:23–35
Di Sabatino A, Ciccocioppo R, Armellini E et al (2004) Serum bFGF and VEGF correlate respectively with bowel wall thickness and intramural blood flow in Crohn’s disease. Inflamm Bowel Dis 10:573–577
Esteban JM, Maldonado L, Sanchiz V et al (2001) Activity of Crohn’s disease assessed by colour Doppler ultrasound analysis of the affected loops. Eur Radiol 11:1423–1428
Fenoglio-Preiser CM, Lantz PE, Listrom MB et al (1989) Gastrointestinal pathology; an atlas and text. Raven Press, New York, pp 427–484
Fraquelli M, Colli A, Casazza G et al (2005) Role of US in detection of Crohn’s disease: meta-analysis. Radiology 236:95–101
Futagami Y, Haruma K, Hata J et al (1999) Development and validation of an US activity index of Crohn’s disease. Eur J Gastroenterol Hepatol 11:1007–1012
Gasche C, Moser G, Turetschek K et al (1999) Transabdominal bowel sonography for detection of intestinal complication in Crohn’s disease. Gut 44:112–117
Goldberg HI, Gore RM, Margulis AR et al (1983) Computed tomography in the evaluation of Crohn’s disease. AJR Am J Roengtenol 140:277–282
Haber HP, Busch A, Ziebach R, Stern M (2000) Bowel wall thickness measured by ultrasound as a marker of Crohn’s disease activity in children. Lancet 355:1239–1240
Haber HP, Busch A, Ziebach R et al (2002) US findings correspond to clinical, endoscopic, and histologic findings in inflammatory bowel disease and other enterocolitides. J Ultrasound Med 21:375–382
Hata J, Haruma K, Yamanaka H et al (1994) US evaluation of the bowel wall in inflammatory bowel disease: comparison of in vivo and in vitro studies. Abdom Imaging 19:395–399
Heyne R, Rickes S, Bock P et al (2002) Non-invasive evaluation of activity in inflammatory bowel disease by power Doppler sonography. Z Gastroenterol 40:171–175
Ko YT, Lim JH, Lee DH et al (1993) Small bowel obstruction: sonographic evaluation. Radiology 188:649–653
Kunihiro K, Hata J, Haruma K et al (2004) Sonographic detection of longitudinal ulcers in Crohn disease. Scand J Gastroenterol 39:322–326
Maconi G, Parente F, Bollani S et al (1996a) Abdominal ultrasound in the assessment of extent and activity of Crohn’s disease: clinical significance and implication of bowel wall thickening. Am J Gastroenterol 91:1604–1609
Maconi G, Bollani S, Bianchi Porro G (1996b) Ultrasonographic detection of intestinal complications in Crohn’s disease. Dig Dis Sci 41:1643–1648
Maconi G, Parente F, Bianchi Porro G (1999) Hydrogen peroxide enhanced ultrasound-fistulography in the assessment of enterocutaneous fistulas complicating Crohn’s disease. Gut 45:874–878
Maconi G, Sampietro GM, Cristaldi M et al (2001) Preoperative characteristics and postoperative behaviour of bowel wall on risk of recurrence after conservative surgery in Crohn’s disease a prospective study. Ann Surg 233:345–352
Maconi G, Sampietro GM, Russo A et al (2002) The vascularity of internal fistulae in Crohn’s disease: an in vivo power Doppler ultrasonography assessment. Gut 50:496–500
Maconi G, Carsana L, Fociani P et al (2003a) Small bowel stenosis in Crohn’s disease: clinical, biochemical and US evaluation of histological features. Aliment Pharmacol Ther 18:749–756
Maconi G, Sampietro GM, Parente F et al (2003b) Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn’s disease: a prospective comparative study. Am J Gastroenterol 98:1545–1555
Maconi G, Greco S, Duca P et al (2008) Prevalence and clinical significance of sonographic evidence of mesenteric fat alterations in Crohn’s disease. Inflamm Bowel Dis 14:1555–1561
Mayer D, Reinshagen M, Mason RA et al (2000) Sonographic measurement of thickened bowel wall segments as a quantitative parameter for activity in inflammatory bowel disease. Z Gastroenterol 38:295–300
Nagler SM, Poticha SM (1979) Intra-abdominal abscesses in regional enteritis. Am J Surg 173:350–354
Neye H, Voderholzer W, Rickes S et al (2004) Evaluation of criteria for the activity of Crohn’s disease by power Doppler sonography. Dig Dis 22:67–72
Nylund K, Leh S, Immervoll H et al (2008) Crohn’s disease: comparison of in vitro ultrasonographic images and histology. Scand J Gastroenterol 43:719–726
Oberhuber G, Stangl PC, Vogelsang H et al (2000) Significant association of strictures and internal fistula formation in Crohn’s disease. Virchows Arch 437:293–297
Panes J, Bouzas R, Chaparro M et al (2011) Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging fro the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther 34:125–145
Parente F, Maconi G, Bollani S et al (2002) Bowel ultrasound in assessment of Crohn’s disease and detection of related small bowel strictures. a prospective comparative study versus X-ray and intraoperative findings. Gut 50:490–495
Parente F, Greco S, Molteni M et al (2003) Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel. Aliment Pharmacol Ther 18:1009–1016
Parente F, Greco S, Molteni M et al (2004a) Modern imaging of Crohn’s disease using bowel ultrasound. Inflamm Bowel Dis 10:452–461
Parente F, Greco S, Molteni M et al (2004b) Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn’s disease. a prospective comparison with conventional ultrasound, x ray studies, and ileocolonoscopy. Gut 53:1652–1657
Rigazio C, Ercole E, Laudi C et al (2009) Abdominal bowel ultrasound can predict the risk of surgery in Crohn’s disease: proposal of an ultrasonographic score. Scand J Gastroenterol 44:585–593
Sarrazin J, Wilson SR (1996) Manifestation of Crohn disease at US. Radiographics 16:499–520
Scholbach T, Herrero I, Scholbach J (2004) Dynamic color Doppler sonography of intestinal wall in patients with Crohn disease compared with healthy subjects. J Pediatr Gastroenterol Nutr 39:524–528
Simpkins KC, Gore RM (1994) Crohn’s disease. In: Gore RM, Levine MS, Laufer I (eds) Textbook of gastrointestinal radiology. Saunders, Philadelphia, pp 2660–2681
Spalinger J, Patriquin H, Miron MC et al (2000) Doppler US in patients with Crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology 217:787–791
Steinberg DM, Cooke WT, Alexander Williams J (1973) Abscesses and fistulae in Crohn’s disease. Gut 14:865–869
Tarjan Z, Toth G, Gyorke T et al (2000) Ultrasound in Crohn’s disease of the small bowel. Eur J Radiol 35:176–182
Truong M, Atri M, Bret PM et al (1998) Sonographic appearance of benign and malignant conditions of the colon. Am J Roentgenol 170:1451–1455
Yekeler E, Danalioglu A, Movasseghi B et al (2005) Crohn disease activity evaluated by Doppler ultrasonography of the superior mesenteric artery and the affected small-bowel segments. J Ultrasound Med 24:59–65
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Maconi, G. (2013). Crohn’s Disease. In: Maconi, G., Bianchi Porro, G. (eds) Ultrasound of the Gastrointestinal Tract. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2013_805
Download citation
DOI: https://doi.org/10.1007/174_2013_805
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-31982-2
Online ISBN: 978-3-642-31983-9
eBook Packages: MedicineMedicine (R0)